Jul 9, 2026
•
5 min read
Plus: Insilico’s AI-designed drug enters Phase III, Biohub finds psoriasis targets in skin cells, and ATHENA teaches medical AI to check its evidence.
Jul 6, 2026
6 min read
Plus: Valence models molecules in water, there's a new Virtual Cell challenge coming up, and Takeda adds Insilico to its AI drug-discovery ecosystem.
TOP 10
Jul 4, 2026
Claude Science, scientific superintelligence, ultrasound through the skull, and AI-designed antibodies for cancer’s hidden mutation flags.
Jul 1, 2026
12 min read
We bring you all the news, how people reacted and the insights behind the launch.
Jun 29, 2026
10 min read
Plus: AI reads more from ECGs, a garage drug candidate goes viral, and BAIO’s AI × bio tools directory is live.
Jun 25, 2026
8 min read
Plus: Proto links biology’s AI silos, AI-CURA reads variant evidence, NVIDIA gives agents a toolbox, and GPT-5 Pro helps revisit a T-cell mystery.
Jun 22, 2026
Plus: OpenAI revisits rare-disease genomes, Benchling adds private lab context, and AlphaFold’s co-creator heads to Anthropic.
Jun 18, 2026
Plus: Tacit Labs builds long-horizon benchmarks for AI drug discovery, Radical Numerics adds a defense layer to genome AI, and Noetik predicts drug responders from pathology slides.
Jun 15, 2026
Plus: Claude Fable goes offline, Terray gives AI-designed molecules a recipe, TITO skips frames in molecular movies, and Tamarind powers Lilly’s TuneLab expansion
Jun 11, 2026
Plus: Tahoe’s shortcut around virtual cells, NewLimit’s AI discovery engine, and AstraZeneca’s Phase 3 agent.
